The investment, which will be paid out over the course of five years, comes in part from industry sources.
A member of the committee issuing a blunt report on the inadequacy of biomarker-based testing speaks about what the next Secretary of HHS needs to do.
The researchers will receive $2 million over three years to study the legalities of translating genomic medicine into clinical applications.
The proposed bill would provide the agency with a $2 billion budget increase for the second year in a row after more than a decade of stagnant funding.
EEOC final rules provide employers clarity on wellness programs, but they may confuse the public about genetic privacy and anti-discrimination laws, some groups said.
Four patients still want the government to investigate their allegations against Myriad, even though the firm complied with their data request at the last hour.
According to ASHG, the final rules, issued this week, will significantly weaken patient privacy protections under ADA and GINA.
Williams is within the time frame in which she can sue, her lawyers maintain, since she didn't know about the lab's "mistake" until last year.
Only 5 percent of respondents said they got tested through a consumer genomics firm, but the future market could be worth as much as $7 billion, analysts at UBS estimated.
Collins did not weigh in on the debate over mandatory versus discretionary budgets, but said that a reduction in NIH funding would be devastating.
The Genetic Research Privacy Protection Act would ensure that federally funded researchers can't reveal genetic data that can identify study participants.
Since CMS has yet to issue a final rule, legislators are worried that the agency will "improperly rush" implementation to meet the Jan.1, 2017 deadline.
The suggested funding is part of Trudeau's proposed 2016 federal budget, which also includes additional financial support for agricultural genomics research.
Since the PMI will take some time and more funds to implement, experts believe legislation is needed to ensure the project has continued support.
FASEB urged Congress to provide the NIH and NSF with increased budgets, citing the importance of biomedical research to human health and the US economy.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
Bill 1392 enumerates various requirements labs would have to follow to provide DTC genetic testing, but doesn't mandate FDA approval or clearance of tests.
The White House said the money would fund a range of biomedical initiatives including ones in precision medicine, cancer treatment and diagnosis, and brain research.
NextGxDx estimates more than 60,000 genetic test products would come under FDA oversight, which, if accurate, industry players fear would overburden test developers.
In his upcoming budget proposal, President Obama intends to ask for $755 million in fiscal 2017 funding to support cancer research programs at the NIH and FDA.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.
CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.
In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.